Synthetic peptides based on Chlamydia trachomatis antigens identify cytotoxic T lymphocyte responses in subjects from a trachoma-endemic population

Clinical and Experimental Immunology

Volumn 107, Issue 1, 1997, Pages 44-49

  Holland, M J ^a,d   Conway, D J ^a   Blanchard, T J ^a,c   Mahdi, O M S ^b   Bailey, R L ^a,b   Whittle, H C ^b   Mabey, D C W ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d MOREDUN RESEARCH INSTITUTE   (United Kingdom)

Author keywords

Cytotoxic T lymphocyte; HLA; Trachoma

Indexed keywords

HEAT SHOCK PROTEIN; HLA B35 ANTIGEN; HLA B8 ANTIGEN; SYNTHETIC PEPTIDE;

ADULT; ARTICLE; CHLAMYDIA TRACHOMATIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HLA SYSTEM; HUMAN; PRIORITY JOURNAL; TRACHOMA;

EID: 0031032260     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.2511129.x     Document Type: Article

References (36)

1. Dawson CR, Jones BR, Tarizzo M L. In: Guide to trachoma control in programs for the prevention of blindness. Geneva: World Health Organisation. 1981.
2. Schachter J, Dawson CR. In: Human chlamydial infections. Littleton: PSG Publishing Co., 1978:63-96.
3. + T cells. Immunology 1992; 77:284-8.
4. + T cells in antichlamydial immunity defined by Chlamydiaspecitic T-lymphocyte clones. Infect Immun 1994; 62:5195-7.
5. Igietseme JU, Ramsey KH, Magee DM, Williams DM, Kincy TJ, Rank RG. Resolution of murine chlamydial genital infection by the adoptive transfer of a biovar-specific, Th1 lymphocyte clone. Reg Immunol 1993; 5:317-24.
6. Ramsey KH, Rank RG. Resolution of chlamydial genital infection with antigen-specific T-lymphocyte lines. Infect Immun 1991; 59:925-31.
7. Landers DV, Erlich K, Sung M, Schachter J. Role of L3T4-bearing T-cell populations in experimental marine salpingitis. Infect Immun 1991; 59:3774-7.
8. Magee DM, Williams DM, Smith JG, Bleicker CA, Grubbs BG, Schachter J, Rank RG. Role of CD8 T cells in primary Chlamydia infection. Infect Immun 1995; 63:516-21.
9. Morrison RP, Feilzer K, Tumas DB. Gene knockout mice establish a primary protective role for major histocompatibility complex class 11-restricted responses in Chlamydia trachomatis genital infection. Infect Immun 1995; 63:4661-8.
10. + T lymphocyte-mediated lysis of Chlamydia-infected L cells using an endogenous antigen pathway. J Immunol 1994; 153:5183-9.
11. Starnbach MN, Bevan MJ, Lampe MF. Protective cytotoxic T lymphocytes are induced during murine infection with Chlanydia trachomatis. J Immunol 1994; 153:5183-9.
12. Kaufmann SHE, Hug E, De Libero G. Listeria monocytogenes reactive T lymphocyte clones with cytolytic activity against infected target cells. J Exp Med 1986; 164:363-8.
13. Orme IM, Miller ES, Roberts AD et al. T Lymphocytes mediating protection and cellular cytolysis during the course of Mycobacterium tuberculosis infection. J Immunol 1992; 148:189-96.
14. + cytotoxic T lymphocytes following primary and secondary Salmonella infection. Immunology 1994; 81:177-82.
15. Rollwagen FM, Dasch GA, Jerrels TR. Mechanisms of immunity to Rickettisial infection: characterisation of a cytotoxic effector cell. J Immunol 1986; 136:1418-21.
16. Conway DJ, Holland MJ, Campbell AE, Bailey RL, Krausa P, Peeling RW, Whittle HC, Mabey DCW. HLA class I and II polymorphisms and trachomatous scarring in a Chlamydia trachomatis-endemic population. J Inf Dis 1996; 174:643-6.
17. Holland MJ, Bailey RL, Conway DJ, Culley F, Miranpuri G, Byrne GI, Whittle HC, Mabey DCW. T helper type-1 (Th1)/Th2 prufiles of peripheral blood mononuclear cells (PBMC); responses to antigens of Chlamydia trachomatis in subjects with severe trachomatous scarring. Clin Exp Immunol 1996; 105:429-35.
18. Kimani J, Maclean IW, Bwayo JJ et al. Risk factors for Chlamydia trachomatis pelvic inflammatory disease among sex workers in Nairobi, Kenya. J Inf Dis 1996; 173:1437-44.
19. Brewerton DA, Caffrey M, Nicholls A, Walters D, Oates JK, James DCO. Reiter's disease and HLA-B27. Lancet 1973; ii:996-8.
20. Allsopp CEM, Harding RM, Taylor C et al. Interethnic genetic differentiation in Africa: HLA class I antigens in The Gambia. Am J Hum Gen 1992; 50:411-21.
21. Taylor HR, Siler JA, Mkocha HA, Munoz B, West S. The natural history of endemic trachoma: a longitudinal study. Am J Trop Med Hyg 1992; 46:552-9.
22. Bailey RL, Holland MJ, Whittle HC, Mabey DCW. Subjects recovering from human ocular chlamydial infection have enhanced lymphoproliferative responses to chlamydial antigens compared with those of persistently diseased controls. Infect Immun 1995; 63:389-92.
23. Hill AVS, Elvin J, Willis A et al. Molecular analysis of the association of HLA-B53 and resistance to severe malaria. Nature 1992; 360:434-9.
24. Elvin J, Cerundolo V, Elliot T, Townsend ARM. A quantitative assay of peptide-dependent class I assembly. Eur J Immunol 1991; 21:2025-31.
25. Dong T, Boyd D, Rosenberg W, Alp N, Takiguchi M, McMichael AJ, Rowland-Jones S. An HLA-B35-restricted epitope modified at an anchor residue results in an antagonist peptide. Eur J Imniunol 1996; 26:336-9.
26. Sutton J, Rowland-Jones S, Rosenburg W et al. A sequence pattern for peptides presented to cytotoxic T lymphocytes by HLA-B8 revealed by analysis of epitopes and eluted peptides. Eur J Immunol 1993; 23:447-53.
27. Tsuji KM, Aizawa M, Sasazuki T. In: HLA 1991. Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Oxford: University of Oxford Press, 1992.
28. Aidoo M, Lalvani A, Allsopp CEM et al. Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria. Lancet 1995; 345:1003-7.
29. Borysiewicz LK, Fiander A, Nimako M et al. A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer. Lancet 1996; 347:1523-7.
30. Qvigstad E, Hirschberg H. Lack of cell mediated cytotoxicity towards Chlamydia trachomatis infected target cells in humans. Acta Path Microbiol Immunol Scand Sect C 1984; 92:153-9.
31. Hassell AB, Pilling D, Reynolds D, Life PF, Bacon PA, Gaston JSH. MHC restriction of synovial fluid lymphocyte responses to the triggering organism in reactive arthritis. Absence of a class I-restricted response. Clin Exp Immunol 1992; 88:442-7.
32. Stagg AJ, Elsley WAJ, Holland MJ, Ward ME, Knight SC. Dendritic cells (DC) in the initiation of immune responses to Chlamydia. In: Mårdh P-A, La Placa M, Ward ME, eds. Proceedings of the European Society for Chlamydia Research 1992:77-80.
33. th International Symposium on human Chlamydial Infections. Bologna: Società Editrice Esculapio, 1994:103-6.
34. Rasmussen SJ, Timms P, Beatty PR, Stephens RS. Cytotoxic-T-lymphocyte-mediated cytolysis of L cells persistently infected with Chlamydia spp. Infect Immun 1996; 64:1944-9.
35. Harboe M, Qualye AJ. Heat shock proteins: friend and foe? Clin Exp Immunol 1991; 86:2-5.
36. Silva CL, Lowry DB. A single mycobacterial protein (hsp65) expressed by a transgenic antigen-presenting cell vaccinates mice against tuberculosis. Immunology 1994; 82:244-8.